BIOMAT Database Logo BIOMAT Database Logo

[Insulin therapy in the complex treatment of destructive pulmonary tuberculosis]. 1980

Iu Ia Agapov, and R E Beresneva, and V S Gavrilenko, and V Ia Sagalovich, and E F Tarasova

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000138 Acidosis A pathologic condition of acid accumulation or depletion of base in the body. The two main types are RESPIRATORY ACIDOSIS and metabolic acidosis, due to metabolic acid build up. Metabolic Acidosis,Acidoses,Acidoses, Metabolic,Acidosis, Metabolic,Metabolic Acidoses
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

Iu Ia Agapov, and R E Beresneva, and V S Gavrilenko, and V Ia Sagalovich, and E F Tarasova
[Complex treatment of destructive pulmonary tuberculosis].
January 2003, Problemy tuberkuleza i boleznei legkikh,
Iu Ia Agapov, and R E Beresneva, and V S Gavrilenko, and V Ia Sagalovich, and E F Tarasova
[Methyluracil in the complex treatment of destructive pulmonary tuberculosis].
November 1980, Problemy tuberkuleza,
Iu Ia Agapov, and R E Beresneva, and V S Gavrilenko, and V Ia Sagalovich, and E F Tarasova
[Colapse therapy in the complex treatment of new cases of destructive pulmonary tuberculosis].
January 2009, Problemy tuberkuleza i boleznei legkikh,
Iu Ia Agapov, and R E Beresneva, and V S Gavrilenko, and V Ia Sagalovich, and E F Tarasova
[Differential pathogenetic therapy in the complex treatment of patients with destructive pulmonary tuberculosis].
February 1982, Problemy tuberkuleza,
Iu Ia Agapov, and R E Beresneva, and V S Gavrilenko, and V Ia Sagalovich, and E F Tarasova
[Use of decaris in the complex treatment of destructive pulmonary tuberculosis].
August 1981, Vrachebnoe delo,
Iu Ia Agapov, and R E Beresneva, and V S Gavrilenko, and V Ia Sagalovich, and E F Tarasova
[Use of ultrasonics in complex treatment of destructive pulmonary tuberculosis].
February 1976, Vrachebnoe delo,
Iu Ia Agapov, and R E Beresneva, and V S Gavrilenko, and V Ia Sagalovich, and E F Tarasova
[NK cells in patients during complex therapy of destructive pulmonary tuberculosis].
January 1989, Problemy tuberkuleza,
Iu Ia Agapov, and R E Beresneva, and V S Gavrilenko, and V Ia Sagalovich, and E F Tarasova
[Pulmonary scintigraphy in evaluating the efficiency of surfactant therapy in the complex treatment of patients with destructive pulmonary tuberculosis].
January 2006, Vestnik rentgenologii i radiologii,
Iu Ia Agapov, and R E Beresneva, and V S Gavrilenko, and V Ia Sagalovich, and E F Tarasova
[Potentialities of collapse therapy in the treatment of destructive pulmonary tuberculosis].
January 2002, Problemy tuberkuleza,
Iu Ia Agapov, and R E Beresneva, and V S Gavrilenko, and V Ia Sagalovich, and E F Tarasova
[Surgical stage in the complex therapy of patients with extensive destructive pulmonary tuberculosis].
January 1970, Problemy tuberkuleza,
Copied contents to your clipboard!